Peizhi Luo

Title: Peizhi Luo: Innovator in Antibody Development

Introduction

Peizhi Luo is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in immune response.

Latest Patents

Peizhi Luo holds a patent for "Anti-PD-L1 antibodies and use thereof." This patent provides antibodies that bind to the T-cell co-inhibitor ligand programmed death-ligand1 (PD-L1) protein, along with methods of use. The antibodies described in the patent are fully human antibodies that effectively bind to PD-L1. Additionally, the patent outlines multi-specific antigen-binding molecules that can target both PD-L1 and tumor cell antigens, which are crucial for treating diseases such as cancer and viral infections. He has 1 patent to his name.

Career Highlights

Peizhi Luo is associated with Adagene Inc., a company focused on innovative antibody therapies. His work has been instrumental in advancing therapeutic options for patients suffering from various diseases.

Collaborations

He has collaborated with notable colleagues, including Fangyong Du and Guizhong Liu, contributing to the collective expertise in antibody research and development.

Conclusion

Peizhi Luo's innovative work in antibody development showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of serious health conditions.